NASDAQ$CMPS

COMPASS Pathways plc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Reported financial results for the third quarter 2024 and provided an update on recent business progress.

Compass Pathways reported a net loss of $38.5 million for the third quarter of 2024. The company is prioritizing its COMP360 program and reducing its workforce by approximately 30%. The company's cash and cash equivalents were $207 million as of September 30, 2024.

  • Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression now expected in second quarter 2025.
  • COMP006 data will now be announced after 26-week time point, expected in the second half of 2026.
  • Strategic reorganization to focus all efforts on COMP360 program resulting in reduction of workforce of approximately 30%.
  • Cash position of $207 million.

Headline financials

Total Revenue

$0.00

Previous: $2.3M-100.0%
EPS (adj)

-$0.56

Previous: -$0.67+16.4%
Capital Expenditures

$0.00

Previous: -$66K+100.0%
Net Income

-$38.5M

Previous: -$33.4M-15.3%
Operating Income

-$48.4M

Previous: -$34.1M-42.1%
Gross Profit

-$59.6K

Previous: $2.3M-102.6%
R&D Expense

$33.3M

Previous: $21.4M+55.4%
Stock-Based Comp

$4.97M

Previous: $4.45M+11.8%

Revenue & EPS history

COMPASS · Revenue · Quarterly

$0

Q3 2024-100%vs Q3 2023

Forward guidance

Fourth quarter 2024 net cash used in operating activities is expected to be in the range of $37 million to $43 million. The full-year 2024 net cash used in operating activities is expected to be in the range of $114 million to $120 million. The cash position at September 30, 2024, is expected to be sufficient to fund operating expenses and capital expenditure requirements at least into 2026.

Tailwinds

  • Sufficient cash to fund operations into 2026.

Headwinds

  • Net cash used in operating activities is expected to be in the range of $37 million to $43 million for Q4 2024.
  • Net cash used in operating activities is expected to be in the range of $114 million to $120 million for full year 2024.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-0.7%

Avg return

Earnings day

+0.6%

Avg return

5 days after

+4.1%

Avg return

30 days after

32%

6 / 19 earnings

Positive

+25.1%

Q2 2022

Best reaction

-23.3%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-5.9%+12.7%+29.1%
Q3 2025-0.5%+4.7%-12.3%
Q1 2025+0.5%+4.3%+28.3%
Q4 2024+5.9%+4.1%-20.5%
Q3 2024-23.3%-27.0%-25.8%
Q1 2024+0.0%-4.9%-18.7%
Q4 2023-7.2%-12.1%-32.7%
Q3 2023+10.9%+4.7%+5.5%
Q2 2023-4.7%-8.8%+4.2%
Q1 2023-4.1%-2.3%-8.7%
Q4 2022-3.4%+0.8%+23.3%
Q3 2022+2.0%-3.9%+14.4%
Q2 2022+25.1%+18.1%+4.6%
Q1 2022-8.2%+3.7%+33.0%
Q4 2021+8.1%+15.5%-1.1%
Q2 2021-5.8%-8.1%+5.4%
Q4 2020-1.2%+4.5%-5.9%
Q4 2019-1.2%+4.5%-5.9%
Q3 2020-0.2%+1.4%+61.6%
Q1 2020
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro